# [18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis

> **NCT02880995** · NA · UNKNOWN · sponsor: **Seoul National University Hospital** · enrollment: 62 (estimated)

## Conditions studied

- Schizophrenia

## Interventions

- **DEVICE:** PET scan
- **BEHAVIORAL:** clinical scale
- **DRUG:** 6 weeks of treatment with amisulpride

## Key facts

- **NCT ID:** NCT02880995
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-11-01
- **Primary completion:** 2019-12
- **Final completion:** 2019-12
- **Target enrollment:** 62 (ESTIMATED)
- **Last updated:** 2019-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02880995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02880995, "[18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02880995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*